Novel Biomarkers Advance Transplant Monitoring and Outcomes
Received Date: Mar 03, 2025 / Published Date: Mar 31, 2025
Abstract
Recent research focuses on novel biomarkers for enhancing transplant outcomes. Studies investigate urinary microRNAs and donor-derived cell-free DNA for early detection of kidney allograft injury and rejection. Other work explores circulating microRNAs for heart transplant rejection, gene expression profiling for liver transplant monitoring, and donor-specific antibodies for kidney transplant survival. Additionally, chemokines, cytokine panels, exosomal proteins, and cfDNA methylation patterns are examined for various rejection types and immune monitoring across different transplant types, aiming for non-invasive and early diagnostic tools to improve graft survival.
Keywords: Biomarkers脥戮 Transplant脥戮 Rejection脥戮 Non-invasive Monitoring脥戮 Early Detection脥戮 MicroRNAs脥戮 Cell-Free DNA脥戮 Cytokines脥戮 Gene Expression脥戮 Allograft Survival
Citation: Svensson I (2025) Novel Biomarkers Advance Transplant Monitoring and Outcomes. J Clin Exp Transplant 10: 282 Doi: 10.4172/2475-7640.1000282
Copyright: © 2025 Ingrid Svensson This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 109
- [From(publication date): 0-0 - Apr 07, 2026]
- Breakdown by view type
- HTML page views: 80
- PDF downloads: 29
